ExodusPoint Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.4K Sell
21,157
-160,537
-88% -$271K ﹤0.01% 1467
2025
Q4
$303K Buy
+181,694
New +$314K ﹤0.01% 1310
2025
Q3
Sell
-19,149
Closed -$17K 1811
2025
Q2
$17K Buy
+19,149
New +$11.4K ﹤0.01% 1387
2023
Q2
Sell
-32,143
Closed -$48K 2079
2023
Q1
$48K Buy
+32,143
New +$44.9K ﹤0.01% 1667
2022
Q1
Sell
-12,142
Closed -$30K 2458
2021
Q4
$30K Buy
+12,142
New +$28.4K ﹤0.01% 2069
2021
Q2
Sell
-334,197
Closed -$785K 2604
2021
Q1
$785K Sell
334,197
-473,415
-59% -$1.14M 0.02% 1064
2020
Q4
$1.42M Buy
807,612
+792,095
+5,105% +$1.11M 0.02% 688
2020
Q3
$15K Buy
15,517
+2,293
+17% +$2.02K ﹤0.01% 1673
2020
Q2
$12K Buy
+13,224
New +$11.6K ﹤0.01% 1715

Other funds holding LCTX